Resonance Health News March 2015

To view our most recent newsletter please click here

ASH Abstract commends FerriScan as "crucial"

A recent abstract from the American Society of Hematology has demonstrated the importance of FerriScan in the management of patients with hemoglobinopathies.

Read more

FerriScan And Cardiac T2* Services Showcased In Europe

Resonance Health exhibited at the Thalassaemia International Federation (TIF) conference in Athens and the UK Forum in London to profile FerriScan and Cardiac T2* services to over 600 delegates from Europe.

Read more

Resonance Health exhibits at AASLD - the world's largest meeting of liver specialists

Resonance Health attended and exhibited at the American Association for the Study of Liver Disease (AASLD) conference in Boston on the 7-11 November.

Read more

Resonance Health - 2014 WA Innovator of the Year Overall Winner

Resonance Health tackles growing prevalence of fatty liver disease and is awarded the 2014 WA Innovator of the Year Overall Winner for HepaFat-Scan

Read more

Resonance Health is Exhibiting at BASL

Resonance Health is excited to be exhibiting at the Annual Meeting of the British Association for the Study of the Liver in England this week - 14th - 18th September 2014.

Read more